Technical Analysis for CPH - Cipher Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 1.24 0.00% 0.000
CPH closed unchanged on Friday, November 15, 2019, on 46 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CPH trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.48%
Bollinger Band Squeeze Range Contraction 2.48%
Calm After Storm Range Contraction 2.48%

Older signals for CPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.
Medicine RTT Organ Systems Psoriasis Acne Actinic Keratosis Rheumatoid Arthritis
Is CPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.35
52 Week Low 1.11
Average Volume 25,635
200-Day Moving Average 1.3881
50-Day Moving Average 1.2964
20-Day Moving Average 1.186
10-Day Moving Average 1.205
Average True Range 0.0751
ADX 23.79
+DI 19.9068
-DI 9.2594
Chandelier Exit (Long, 3 ATRs ) 1.1247
Chandelier Exit (Short, 3 ATRs ) 1.3553
Upper Bollinger Band 1.2461
Lower Bollinger Band 1.1259
Percent B (%b) 0.95
BandWidth 10.134907
MACD Line -0.0118
MACD Signal Line -0.0252
MACD Histogram 0.0135
Fundamentals Value
Market Cap 33.01 Million
Num Shares 26.6 Million
EPS -1.34
Price-to-Earnings (P/E) Ratio -0.93
Price-to-Sales 2.68
Price-to-Book 7.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.315
Resistance 3 (R3) 1.307 1.273 1.303
Resistance 2 (R2) 1.273 1.254 1.278 1.298
Resistance 1 (R1) 1.257 1.242 1.265 1.265 1.294
Pivot Point 1.223 1.223 1.228 1.228 1.223
Support 1 (S1) 1.207 1.204 1.215 1.215 1.186
Support 2 (S2) 1.173 1.192 1.178 1.182
Support 3 (S3) 1.157 1.173 1.178
Support 4 (S4) 1.165